Follow
Sapana Bansod
Sapana Bansod
Post-Doctorate Research Associate, Washington University School of Medicine
Verified email at wustl.edu
Title
Cited by
Cited by
Year
Berberine attenuates severity of chronic pancreatitis and fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling and M2 polarization
S Bansod, N Doijad, C Godugu
Toxicology and Applied Pharmacology 403, 115162, 2020
362020
Borneol protects against cerulein‐induced oxidative stress and inflammation in acute pancreatitis mice model
S Bansod, S Chilvery, MA Saifi, TJ Das, H Tag, C Godugu
Environmental Toxicology 36 (4), 530-539, 2021
332021
Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-β1/Smad and EMT pathways
S Chilvery, S Bansod, MA Saifi, C Godugu
International Immunopharmacology 88, 106909, 2020
322020
Crocin, an active constituent of Crocus sativus ameliorates cerulein induced pancreatic inflammation and oxidative stress
C Godugu, LP Pasari, A Khurana, P Anchi, MA Saifi, SP Bansod, ...
Phytotherapy research 34 (4), 825-835, 2020
322020
Molecular updates on berberine in liver diseases: bench to bedside
S Bansod, MA Saifi, C Godugu
Phytotherapy Research 35 (10), 5459-5476, 2021
232021
Nimbolide ameliorates pancreatic inflammation and apoptosis by modulating NF-κB/SIRT1 and apoptosis signaling in acute pancreatitis model
S Bansod, C Godugu
International Immunopharmacology 90, 107246, 2021
232021
Nimbolide abrogates cerulein-induced chronic pancreatitis by modulating β-catenin/Smad in a sirtuin-dependent way
S Bansod, MA Saifi, A Khurana, C Godugu
Pharmacological Research 156, 104756, 2020
222020
Cerulein-induced chronic pancreatitis in Swiss albino mice: An improved short-term model for pharmacological screening
S Bansod, A Khurana, C Godugu
Journal of pharmacological and toxicological methods 96, 46-55, 2019
182019
Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities
S Bansod, PB Dodhiawala, KH Lim
Cancers 13 (21), 5481, 2021
122021
Acetaminophen induced hepatotoxicity: An overview of the promising protective effects of natural products and herbal formulations
S Chilvery, A Yelne, A Khurana, MA Saifi, S Bansod, P Anchi, C Godugu
Phytomedicine 108, 154510, 2023
112023
New 3‐(1H‐benzo[d]imidazol‐2‐yl)quinolin‐2(1H)‐one‐based triazole derivatives: Design, synthesis, and biological evaluation as antiproliferative and apoptosis …
NB Gaikwad, S Bansode, S Biradar, M Ban, N Srinivas, C Godugu, ...
Archiv der Pharmazie 354 (11), 2100074, 2021
82021
Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model
S Bansod, MA Saifi, C Godugu
Scientific Reports 11 (1), 12894, 2021
82021
COVID-19 and fibrosis: Mechanisms, clinical relevance, and future perspectives
MA Saifi, S Bansod, C Godugu
Drug Discovery Today 27 (11), 103345, 2022
72022
Design, synthesis, and biological evaluation of N-(4-substituted)-3-phenylisoxazolo [5, 4–d] pyrimidin-4-amine derivatives as apoptosis-inducing cytotoxic agents
NB Gaikwad, S Bansod, A Mara, R Garise, N Srinivas, C Godugu, ...
Bioorganic & Medicinal Chemistry Letters 49, 128294, 2021
72021
A brief cross-cultural ethnobotanical note on the Abotani tribes of Arunachal Pradesh, India
H Yanka, R Rinyo, SK Das, TJ Das, D Paul, DD Gupta, PK Hui, S Bansod, ...
Pleione 13 (2), 269-283, 2019
62019
Ethnobotanical notes on significant food and medicinal flora used by the indigenous Monpa and Nyishi communities of Arunachal Pradesh, India
SK Das, TJ Das, D Tshering, J Tsering, D Paul, DD Gupta, H Yanka, ...
Pleione 13, 291-304, 2019
42019
Exploration of cytotoxic potential and tubulin polymerization inhibition activity of cis-stilbene-1, 2, 3-triazole congeners
D Bora, KM Samir, A Sharma, S Chilvery, S Bansod, SE John, MA Khan, ...
RSC Medicinal Chemistry 14 (3), 482-490, 2023
32023
Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer
A Bulle, P Liu, K Seehra, S Bansod, Y Chen, K Zahra, V Somani, ...
Nature Communications 15 (1), 2503, 2024
22024
A pilot study of paricalcitol plus nanoliposomal irinotecan and 5-FU/LV in advanced pancreatic cancer patients after progression on gemcitabine-based therapy
PM Grierson, R Suresh, B Tan, KS Pedersen, M Amin, H Park, ...
Clinical Cancer Research 29 (23), 4733-4739, 2023
2023
A pilot study of liposomal irinotecan plus 5-FU/LV combined with paricalcitol in patients with advanced pancreatic cancer whose disease progressed on gemcitabine-based therapy.
P Grierson, R Suresh, BR Tan, KS Pedersen, MA Amin, H Park, ...
Journal of Clinical Oncology 41 (16_suppl), e16263-e16263, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20